Health ❯ Healthcare ❯ Clinical Trials

Drug Development

Combination Therapy Phase 3 Trials Eli Lilly Targeted Therapy Alzheimer's Treatments Phase III Trials Oncology Daraxonrasib Patient Outcomes RAS Inhibitors

Copper Compound Restores Brain Pump and Cuts Alzheimer’s Proteins in Mice

The study supports early human testing by showing the drug repairs the blood–brain barrier, lowers amyloid, improves memory in a mouse model

Stories older than 24h

Sanofi Stops MOBILIZE Phase 3 Trial of Riliprubart in CIDP After Futility Finding

Roche Stops Phase 3 for Acmopatide After Positive Phase 2 in Type 1 Diabetes

Abivax Drug Shows Breakthrough Ulcerative Colitis Results as Shares Plunge After Cancer Cases

Daraxonrasib Nearly Doubles Median Survival in Previously Treated Metastatic Pancreatic Cancer

Experimental ERAP1 Inhibitor Plus Immunotherapy Shrinks Tumours in Early Trial

Praxis Drug Vormatrigine Misses Primary Goal in Phase 2/3 POWER1 Trial

Daraxonrasib Doubles Survival in Treated Metastatic Pancreatic Cancer in Phase 3 Trial

Erleada Plus Hormone Therapy Cuts Recurrence and Death in High‑Risk Localized Prostate Cancer

Phase 1 TCER IMA401 Shows Early Safety and Tumor Responses in Solid Cancers

Mezigdomide Triplet Cuts Risk of Myeloma Progression by 52% in Phase 3 Trial

NEJM Paper Shows Zanidatamab Triplet Extends Survival Over Trastuzumab in First‑Line HER2+ Gastroesophageal Cancer

Lilly’s Triple‑Agonist Retatrutide Produces Surgery‑Level Weight Loss in Phase 3 Trial

Sacituzumab Tirumotecan With Keytruda Improves Progression-Free Survival in China Phase 3 Lung Cancer Trial

FDA Approves Baxfendy, First Aldosterone Synthase Inhibitor for Uncontrolled Hypertension

Sanofi’s Efdoralprin Alfa Beats Standard Therapy in Phase 2 AATD Trial

FDA Approves Bizengri for NRG1 Fusion-Positive Cholangiocarcinoma

NEJM Study and FDA Access Advance Daraxonrasib for Pancreatic Cancer

Avalo Therapeutics Reports Positive Phase 2 HS Results, Prices $375 Million Offering

FDA Authorizes Early Access to Daraxonrasib for Pancreatic Cancer Patients